Investing In Ketamine Clinics? Key Legal and Practical Considerations for Investors October 29, 2026

Interest in psychedelic-assisted psychotherapy, including treatments involving ketamine, psilocybin, and 3,4-Methylenedioxymethamphetamine (MDMA), continues to attract investors, entrepreneurs, and health care operators. Ketamine clinics in particular have emerged as an accessible entry point because ketamine is already an approved drug that practitioners may prescribe, while other psychedelic substances remain subject to far more restrictive federal and […]